Majority of Indian adults seek non-drug weight loss options amid safety concerns over GLP-1…
New survey highlights rising public interest in sustainable, plant-based alternatives to semaglutide and tirzepatide as health…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
ACG appoints Nikhil Kulkarni as Group CEO of Engineering division
Kulkarni to oversee strategic direction of ACG Engineering from Pune, reporting to Managing Director Karan Singh
Veeda Lifesciences invests in Mango Sciences to integrate AI into global clinical trial operations
Partnership aims to enhance oncology trial recruitment and diversity using Mango Sciences’ AI-powered Querent platform
Fette Compacting India and Goa College of Pharmacy join hands to upskill Goa pharma students
Fette Compacting India and Goa College of Pharmacy sign MoU to provide hands-on training and digital certification in tablet…
Beauty, boosters and the law: Who’s watching India’s wellness market?
Biplab Lenin, Partner; and Anam Chowdhary, Associate, Cyril Amarchand Mangaldas, stress that regulatory vigilance on the…
Eisai selected as Supplier Engagement Leader by CDP
The Supplier Engagement Assessment evaluates how effectively companies are working with suppliers to address climate change issues…
CDC’s vaccine advisory committee overhaul raises concerns for vaccine oversight: GlobalData
GlobalData reveals that ADCs are expected to emerge as the fastest-growing category of medicines in the innovation pipeline for…
Auriga Research, SFRI sign MoU to build AI-integrated, globally compliant healthcare ecosystem
The partnership outlines a joint framework to support clinical trials, regulatory pathways, digital health innovation, and…
Biocon Biologics gains UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars
Vevzuo is authorised for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord…
Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData
According to GlobalData’s latest report, there is set to be a smaller proportion of global drug sales which will have patent…
Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent in…
The medication is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis…
Endometriosis market to grow to $2.5 bn across 7MM in 2034
GlobalData’s latest report reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction…
Funding declines in pharma as June sees 97% plunge
Total funding reached $7.2 million across 5 rounds, representing a 97.07 per cent decrease from May 2025
Parexel appoints two FDA luminaries, Dr Lola Fashoyin-Aje, and Dr Tala Fakhouri to its Consulting…
These strategic appointments will bolster the company’s regulatory expertise
EU approves Biocon Biologics’ Denosumab biosimilars
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor…
Vaccine sales plummet in China, posing a challenge for big pharma: GlobalData
GlobalData attributes this drop to price competition from local manufacturers and China’s ongoing anti-corruption crackdown on the…
Nymi, Caliber Technologies partner to enable Passwordless Authentication in Pharma Manufacturing
This collaboration aims to strengthen MES, LIMS, and QMS automation by reducing manual logins and streamlining electronic…
Pharmexcil reports robust exports: $ 2,475.70 mn in May 2025, Cumulating to $ 4,961.71 mn for…
According to the reports, a 7.38 per cent expansion was observed compared to May 2024-25
Asahi Kasei Pharma starts Phase III study of CIPN prevention therapy
Previous Phase I and II studies suggest efficacy and patient tolerability of ART-123 for CIPN by suppressing the activation of…
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country
Durvalumab in combination with carboplatin and paclitaxel is now also indicated for first-line treatment of adults with primary…